Dartmouth Atlas Area-Level Estimates of End-of-Life Expenditures: How Well Do They Reflect Expenditures for Prospectively Identified Advanced Lung Cancer Patients?

Nancy L. Keating, Mary Beth Landrum, Haiden A. Huskamp, Elena M. Kouri, Holly G. Prigerson, Deborah Schrag, Paul K. Maciejewski, Mark C. Hornbrook, David Haggstrom

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: Assess validity of the retrospective Dartmouth hospital referral region (HRR) end-of-life spending measures by comparing with health care expenditures from diagnosis to death for prospectively identified advanced lung cancer patients. Data/Setting/Design: We calculated health care spending from diagnosis (2003–2005) to death or through 2011 for 885 patients aged ≥65 years with advanced lung cancer using Medicare claims. We assessed the association between Dartmouth HRR-level spending in the last 2 years of life and patient-level spending using linear regression with random HRR effects, adjusting for patient characteristics. Findings: For each $1 increase in the Dartmouth metric, spending for our cohort increased by $0.74 (p < .001). The Dartmouth spending variable explained 93.4 percent of the HRR-level variance in observed spending. Conclusions: HRR-level spending estimates for deceased patient cohorts reflect area-level care intensity for prospectively identified advanced lung cancer patients.

Original languageEnglish (US)
Pages (from-to)1584-1594
Number of pages11
JournalHealth Services Research
Volume51
Issue number4
DOIs
StatePublished - Aug 1 2016

Fingerprint

Atlases
Health Expenditures
Lung Neoplasms
Referral and Consultation
Delivery of Health Care
Medicare
Linear Models

Keywords

  • health care expenditures
  • lung cancer
  • Variation

ASJC Scopus subject areas

  • Health Policy

Cite this

Dartmouth Atlas Area-Level Estimates of End-of-Life Expenditures : How Well Do They Reflect Expenditures for Prospectively Identified Advanced Lung Cancer Patients? / Keating, Nancy L.; Landrum, Mary Beth; Huskamp, Haiden A.; Kouri, Elena M.; Prigerson, Holly G.; Schrag, Deborah; Maciejewski, Paul K.; Hornbrook, Mark C.; Haggstrom, David.

In: Health Services Research, Vol. 51, No. 4, 01.08.2016, p. 1584-1594.

Research output: Contribution to journalArticle

Keating, Nancy L. ; Landrum, Mary Beth ; Huskamp, Haiden A. ; Kouri, Elena M. ; Prigerson, Holly G. ; Schrag, Deborah ; Maciejewski, Paul K. ; Hornbrook, Mark C. ; Haggstrom, David. / Dartmouth Atlas Area-Level Estimates of End-of-Life Expenditures : How Well Do They Reflect Expenditures for Prospectively Identified Advanced Lung Cancer Patients?. In: Health Services Research. 2016 ; Vol. 51, No. 4. pp. 1584-1594.
@article{ba23b9a98b024b9abbbf6cdf97358ede,
title = "Dartmouth Atlas Area-Level Estimates of End-of-Life Expenditures: How Well Do They Reflect Expenditures for Prospectively Identified Advanced Lung Cancer Patients?",
abstract = "Objective: Assess validity of the retrospective Dartmouth hospital referral region (HRR) end-of-life spending measures by comparing with health care expenditures from diagnosis to death for prospectively identified advanced lung cancer patients. Data/Setting/Design: We calculated health care spending from diagnosis (2003–2005) to death or through 2011 for 885 patients aged ≥65 years with advanced lung cancer using Medicare claims. We assessed the association between Dartmouth HRR-level spending in the last 2 years of life and patient-level spending using linear regression with random HRR effects, adjusting for patient characteristics. Findings: For each $1 increase in the Dartmouth metric, spending for our cohort increased by $0.74 (p < .001). The Dartmouth spending variable explained 93.4 percent of the HRR-level variance in observed spending. Conclusions: HRR-level spending estimates for deceased patient cohorts reflect area-level care intensity for prospectively identified advanced lung cancer patients.",
keywords = "health care expenditures, lung cancer, Variation",
author = "Keating, {Nancy L.} and Landrum, {Mary Beth} and Huskamp, {Haiden A.} and Kouri, {Elena M.} and Prigerson, {Holly G.} and Deborah Schrag and Maciejewski, {Paul K.} and Hornbrook, {Mark C.} and David Haggstrom",
year = "2016",
month = "8",
day = "1",
doi = "10.1111/1475-6773.12440",
language = "English (US)",
volume = "51",
pages = "1584--1594",
journal = "Health Services Research",
issn = "0017-9124",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Dartmouth Atlas Area-Level Estimates of End-of-Life Expenditures

T2 - How Well Do They Reflect Expenditures for Prospectively Identified Advanced Lung Cancer Patients?

AU - Keating, Nancy L.

AU - Landrum, Mary Beth

AU - Huskamp, Haiden A.

AU - Kouri, Elena M.

AU - Prigerson, Holly G.

AU - Schrag, Deborah

AU - Maciejewski, Paul K.

AU - Hornbrook, Mark C.

AU - Haggstrom, David

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Objective: Assess validity of the retrospective Dartmouth hospital referral region (HRR) end-of-life spending measures by comparing with health care expenditures from diagnosis to death for prospectively identified advanced lung cancer patients. Data/Setting/Design: We calculated health care spending from diagnosis (2003–2005) to death or through 2011 for 885 patients aged ≥65 years with advanced lung cancer using Medicare claims. We assessed the association between Dartmouth HRR-level spending in the last 2 years of life and patient-level spending using linear regression with random HRR effects, adjusting for patient characteristics. Findings: For each $1 increase in the Dartmouth metric, spending for our cohort increased by $0.74 (p < .001). The Dartmouth spending variable explained 93.4 percent of the HRR-level variance in observed spending. Conclusions: HRR-level spending estimates for deceased patient cohorts reflect area-level care intensity for prospectively identified advanced lung cancer patients.

AB - Objective: Assess validity of the retrospective Dartmouth hospital referral region (HRR) end-of-life spending measures by comparing with health care expenditures from diagnosis to death for prospectively identified advanced lung cancer patients. Data/Setting/Design: We calculated health care spending from diagnosis (2003–2005) to death or through 2011 for 885 patients aged ≥65 years with advanced lung cancer using Medicare claims. We assessed the association between Dartmouth HRR-level spending in the last 2 years of life and patient-level spending using linear regression with random HRR effects, adjusting for patient characteristics. Findings: For each $1 increase in the Dartmouth metric, spending for our cohort increased by $0.74 (p < .001). The Dartmouth spending variable explained 93.4 percent of the HRR-level variance in observed spending. Conclusions: HRR-level spending estimates for deceased patient cohorts reflect area-level care intensity for prospectively identified advanced lung cancer patients.

KW - health care expenditures

KW - lung cancer

KW - Variation

UR - http://www.scopus.com/inward/record.url?scp=84978299743&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978299743&partnerID=8YFLogxK

U2 - 10.1111/1475-6773.12440

DO - 10.1111/1475-6773.12440

M3 - Article

C2 - 26799913

AN - SCOPUS:84978299743

VL - 51

SP - 1584

EP - 1594

JO - Health Services Research

JF - Health Services Research

SN - 0017-9124

IS - 4

ER -